Puretech Health Plc Stock Current Ratio
| PTCHF Stock | USD 1.68 0.00 0.00% |
Fundamental analysis of PureTech Health allows traders to better anticipate movements in PureTech Health's stock price by examining its financial health and performance throughout various phases of its business cycle.
PureTech |
PureTech Health plc Company Current Ratio Analysis
PureTech Health's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current PureTech Health Current Ratio | 2.54 X |
Most of PureTech Health's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PureTech Health plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, PureTech Health plc has a Current Ratio of 2.54 times. This is 12.71% lower than that of the Healthcare sector and 63.71% lower than that of the Biotechnology industry. The current ratio for all United States stocks is 17.59% lower than that of the firm.
PureTech Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PureTech Health's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of PureTech Health could also be used in its relative valuation, which is a method of valuing PureTech Health by comparing valuation metrics of similar companies.PureTech Health is currently under evaluation in current ratio category among its peers.
PureTech Fundamentals
| Return On Equity | -0.0152 | |||
| Return On Asset | -0.13 | |||
| Profit Margin | (0.73) % | |||
| Operating Margin | (9.87) % | |||
| Current Valuation | 654.5 M | |||
| Shares Outstanding | 278.81 M | |||
| Shares Owned By Insiders | 15.48 % | |||
| Shares Owned By Institutions | 72.20 % | |||
| Price To Earning | 158.00 X | |||
| Price To Book | 1.61 X | |||
| Price To Sales | 51.23 X | |||
| Revenue | 9.98 M | |||
| Gross Profit | 17.39 M | |||
| EBITDA | (46.95 M) | |||
| Net Income | (60.56 M) | |||
| Cash And Equivalents | 368.03 M | |||
| Cash Per Share | 1.28 X | |||
| Total Debt | 14.26 M | |||
| Debt To Equity | 0.08 % | |||
| Current Ratio | 2.54 X | |||
| Book Value Per Share | 2.03 X | |||
| Cash Flow From Operations | (158.27 M) | |||
| Earnings Per Share | (0.21) X | |||
| Target Price | 3.5 | |||
| Number Of Employees | 95 | |||
| Beta | 0.83 | |||
| Market Capitalization | 901.7 M | |||
| Total Asset | 946.01 M | |||
| Z Score | 37.8 | |||
| Net Asset | 946.01 M |
About PureTech Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PureTech Health plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PureTech Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PureTech Health plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| PRNEX | T Rowe Price | |
| RPBAX | T Rowe Price | |
| PRDGX | T Rowe Price | |
| PRFDX | T Rowe Price | |
| RPBAX | T Rowe Price |
Additional Information and Resources on Investing in PureTech Pink Sheet
When determining whether PureTech Health plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PureTech Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Puretech Health Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Puretech Health Plc Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PureTech Health plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.